$DOVP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Euthymics Bioscience, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Euthymics Bioscience, Inc.. Get notifications about new insider transactions in Euthymics Bioscience, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 04 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Sr. V.P. Research, ... | Buy | C | 2.78 | 5,000 | 13,900 | 5,000 | 0 to 5 K |
Sep 09 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Sr. V.P. & CSO | Option Exercise | C | 2.78 | 5,000 | 13,900 | 445,000 | |
Sep 09 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Sr. V.P. & CSO | Sell | S | 15.82 | 5,000 | 79,100 | 0 | 5 K to 0 (-100.00 %) |
Sep 09 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Sr. V.P. & CSO | Buy | C | 2.78 | 5,000 | 13,900 | 5,000 | 0 to 5 K |
Aug 29 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 18.00 | 33,300 | 599,400 | 955,900 | 989.2 K to 955.9 K (-3.37 %) |
Aug 17 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Option Exercise | C | 2.47 | 15,000 | 37,050 | 112,200 | |
Aug 17 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 18.17 | 15,000 | 272,510 | 50,200 | 65.2 K to 50.2 K (-23.01 %) |
Aug 17 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Buy | C | 2.47 | 15,000 | 37,050 | 65,200 | 50.2 K to 65.2 K (+29.88 %) |
Jul 29 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Senior V.P. & Gener ... | Option Exercise | A | 21.15 | 100,000 | 2,115,000 | 300,000 | |
Aug 16 2005 | DOVP | Euthymics Bioscien ... | ORBIMED ADVISORS LLC | Director | Sell | S | 18.24 | 138,400 | 2,524,416 | 2,028,028 | 2.2 M to 2 M (-6.39 %) |
Aug 16 2005 | DOVP | Euthymics Bioscien ... | ORBIMED ADVISORS LLC | Director | Sell | S | 18.47 | 85,000 | 1,569,950 | 2,166,428 | 2.3 M to 2.2 M (-3.78 %) |
Jul 29 2005 | DOVP | Euthymics Bioscien ... | Hudson Leslie | CEO and President | Option Exercise | A | 21.20 | 225,000 | 4,770,000 | 225,000 | |
Jul 29 2005 | DOVP | Euthymics Bioscien ... | Hudson Leslie | CEO and President | Grant | A | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
Jun 28 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Option Exercise | C | 2.47 | 15,000 | 37,050 | 25,500 | |
Jun 28 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 18.30 | 2,500 | 45,750 | 50,200 | 52.7 K to 50.2 K (-4.74 %) |
Jun 28 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 18.02 | 2,500 | 45,050 | 52,700 | 55.2 K to 52.7 K (-4.53 %) |
Jun 28 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 18.00 | 2,500 | 45,000 | 55,200 | 57.7 K to 55.2 K (-4.33 %) |
Jun 28 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 17.96 | 7,500 | 134,700 | 57,700 | 65.2 K to 57.7 K (-11.50 %) |
Jun 28 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Buy | C | 2.47 | 15,000 | 37,050 | 65,200 | 50.2 K to 65.2 K (+29.88 %) |
May 31 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Option Exercise | A | 15.05 | 15,000 | 225,750 | 57,150 | |
May 31 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Option Exercise | A | 15.05 | 15,000 | 225,750 | 142,200 | |
May 31 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Option Exercise | A | 15.05 | 15,000 | 225,750 | 39,300 | |
May 31 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Option Exercise | A | 15.05 | 15,000 | 225,750 | 121,200 | |
May 25 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | CEO and President | Grant | A | 0.00 | 60,000 | 0 | 989,200 | 929.2 K to 989.2 K (+6.46 %) |
May 17 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Option Exercise | C | 6.17 | 12,150 | 74,966 | 42,150 | |
May 17 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.67 | 3,150 | 49,361 | 0 | 3.2 K to 0 (-100.00 %) |
May 17 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.66 | 3,000 | 46,980 | 3,150 | 6.2 K to 3.2 K (-48.78 %) |
May 17 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.65 | 2,500 | 39,125 | 6,150 | 8.7 K to 6.2 K (-28.90 %) |
May 17 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.68 | 2,500 | 39,200 | 8,650 | 11.2 K to 8.7 K (-22.42 %) |
May 17 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.66 | 1,000 | 15,660 | 11,150 | 12.2 K to 11.2 K (-8.23 %) |
May 17 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Buy | C | 6.17 | 12,150 | 74,966 | 12,150 | 0 to 12.2 K |
Mar 23 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Senior V.P. & Gener ... | Option Exercise | C | 4.40 | 50,000 | 220,000 | 200,000 | |
Mar 23 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Senior V.P. & Gener ... | Buy | C | 4.40 | 50,000 | 220,000 | 50,000 | 0 to 50 K |
Feb 03 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Option Exercise | A | 16.77 | 45,000 | 754,650 | 280,600 | |
Feb 03 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Sr. V.P. Research C ... | Option Exercise | A | 16.77 | 25,000 | 419,250 | 450,000 | |
Feb 03 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | V.P. & General Coun ... | Option Exercise | A | 16.77 | 25,000 | 419,250 | 250,000 | |
Feb 03 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Sr. V.P. Drug Devel ... | Option Exercise | A | 16.77 | 25,000 | 419,250 | 310,000 | |
Jan 06 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Chief Financial Off ... | Option Exercise | M | 4.01 | 25,000 | 100,250 | 339,500 | |
Nov 12 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Option Exercise | M | 2.73 | 21,000 | 57,330 | 127,200 | |
Nov 12 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 16.46 | 21,000 | 345,660 | 50,200 | 71.2 K to 50.2 K (-29.49 %) |
Nov 12 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Option Exercise | M | 2.73 | 21,000 | 57,330 | 127,200 | |
Nov 12 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 16.46 | 21,000 | 345,660 | 50,200 | 71.2 K to 50.2 K (-29.49 %) |
Sep 21 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 16.24 | 40,000 | 649,600 | 21,000 | 61 K to 21 K (-65.57 %) |
Sep 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 16.19 | 6,000 | 97,140 | 859,245 | 865.2 K to 859.2 K (-0.69 %) |
Sep 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 16.20 | 15,000 | 243,000 | 865,245 | 880.2 K to 865.2 K (-1.70 %) |
Sep 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 16.21 | 10,000 | 162,100 | 880,245 | 890.2 K to 880.2 K (-1.12 %) |
Sep 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 16.23 | 27,500 | 446,325 | 890,245 | 917.7 K to 890.2 K (-3.00 %) |
Sep 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 16.17 | 16,500 | 266,805 | 917,745 | 934.2 K to 917.7 K (-1.77 %) |
Sep 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 16.14 | 5,000 | 80,700 | 934,245 | 939.2 K to 934.2 K (-0.53 %) |
Sep 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 16.12 | 5,000 | 80,600 | 939,245 | 944.2 K to 939.2 K (-0.53 %) |
Sep 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 16.10 | 5,000 | 80,500 | 944,245 | 949.2 K to 944.2 K (-0.53 %) |
Sep 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 16.15 | 5,000 | 80,750 | 949,245 | 954.2 K to 949.2 K (-0.52 %) |
Sep 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 16.09 | 5,000 | 80,450 | 954,245 | 959.2 K to 954.2 K (-0.52 %) |
Aug 27 2004 | DOVP | Euthymics Bioscien ... | ELAN CORP PLC | 10% Owner | Sell | S | 14.75 | 1,945,362 | 28,694,090 | 0 | 1.9 M to 0 (-100.00 %) |
Aug 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.30 | 25,000 | 382,500 | 929,200 | 954.2 K to 929.2 K (-2.62 %) |
Aug 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.24 | 50,000 | 762,000 | 954,200 | 1 M to 954.2 K (-4.98 %) |
Aug 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.21 | 14,834 | 225,625 | 1,004,200 | 1 M to 1 M (-1.46 %) |
Aug 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.09 | 23,632 | 356,607 | 1,019,034 | 1 M to 1 M (-2.27 %) |
Aug 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.21 | 38,744 | 589,296 | 1,042,666 | 1.1 M to 1 M (-3.58 %) |
Aug 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.51 | 3,000 | 46,530 | 1,081,410 | 1.1 M to 1.1 M (-0.28 %) |
Aug 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.13 | 25,000 | 378,250 | 1,084,410 | 1.1 M to 1.1 M (-2.25 %) |
Aug 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.38 | 8,256 | 126,977 | 1,109,410 | 1.1 M to 1.1 M (-0.74 %) |
Aug 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.38 | 25,000 | 384,500 | 1,117,666 | 1.1 M to 1.1 M (-2.19 %) |
Aug 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.12 | 1,368 | 20,684 | 1,142,666 | 1.1 M to 1.1 M (-0.12 %) |
Aug 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.18 | 25,000 | 379,500 | 1,144,034 | 1.2 M to 1.1 M (-2.14 %) |
Aug 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.11 | 25,000 | 377,750 | 1,169,034 | 1.2 M to 1.2 M (-2.09 %) |
Aug 25 2004 | DOVP | Euthymics Bioscien ... | ELAN CORP PLC | 10% Owner | Sell | S | 15.25 | 250,000 | 3,812,500 | 1,945,362 | 2.2 M to 1.9 M (-11.39 %) |
Aug 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.23 | 2,500 | 38,075 | 1,023,730 | 1 M to 1 M (-0.24 %) |
Aug 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.14 | 5,000 | 75,700 | 1,026,230 | 1 M to 1 M (-0.48 %) |
Aug 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.17 | 2,500 | 37,925 | 1,031,230 | 1 M to 1 M (-0.24 %) |
Aug 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.09 | 15,000 | 226,350 | 1,033,730 | 1 M to 1 M (-1.43 %) |
Aug 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.25 | 10,000 | 152,500 | 1,048,730 | 1.1 M to 1 M (-0.94 %) |
Aug 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.21 | 5,000 | 76,050 | 1,058,730 | 1.1 M to 1.1 M (-0.47 %) |
Aug 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.10 | 20,000 | 302,000 | 1,063,730 | 1.1 M to 1.1 M (-1.85 %) |
Aug 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.08 | 5,000 | 75,400 | 1,083,730 | 1.1 M to 1.1 M (-0.46 %) |
Aug 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.06 | 2,500 | 37,650 | 1,088,730 | 1.1 M to 1.1 M (-0.23 %) |
Aug 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.05 | 12,500 | 188,125 | 1,091,230 | 1.1 M to 1.1 M (-1.13 %) |
Aug 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.07 | 15,000 | 226,050 | 1,103,730 | 1.1 M to 1.1 M (-1.34 %) |
Aug 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.40 | 5,000 | 77,000 | 1,118,730 | 1.1 M to 1.1 M (-0.44 %) |
Aug 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.37 | 5,000 | 76,850 | 1,123,730 | 1.1 M to 1.1 M (-0.44 %) |
Aug 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.33 | 5,000 | 76,650 | 1,128,730 | 1.1 M to 1.1 M (-0.44 %) |
Aug 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.31 | 5,000 | 76,550 | 1,133,730 | 1.1 M to 1.1 M (-0.44 %) |
Aug 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.07 | 10,000 | 150,700 | 1,138,730 | 1.1 M to 1.1 M (-0.87 %) |
Aug 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.12 | 15,000 | 226,800 | 1,148,730 | 1.2 M to 1.1 M (-1.29 %) |
Aug 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.20 | 30,000 | 456,000 | 1,163,730 | 1.2 M to 1.2 M (-2.51 %) |
Aug 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.25 | 12,000 | 183,000 | 959,245 | 971.2 K to 959.2 K (-1.24 %) |
Aug 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.21 | 10,000 | 152,100 | 971,245 | 981.2 K to 971.2 K (-1.02 %) |
Aug 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.22 | 7,485 | 113,922 | 981,245 | 988.7 K to 981.2 K (-0.76 %) |
Aug 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.27 | 5,000 | 76,350 | 988,730 | 993.7 K to 988.7 K (-0.50 %) |
Aug 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.31 | 5,000 | 76,550 | 993,730 | 998.7 K to 993.7 K (-0.50 %) |
Aug 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.22 | 15,000 | 228,300 | 998,730 | 1 M to 998.7 K (-1.48 %) |
Aug 16 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.25 | 10,000 | 152,500 | 1,013,730 | 1 M to 1 M (-0.98 %) |
Aug 12 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | V.P. & General Coun ... | Option Exercise | M | 4.40 | 25,000 | 110,000 | 200,000 | |
Aug 12 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | V.P. & General Coun ... | Option Exercise | M | 4.40 | 25,000 | 110,000 | 225,000 | |
Aug 12 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | V.P. & General Coun ... | Sell | S | 15.20 | 25,000 | 380,000 | 0 | 25 K to 0 (-100.00 %) |
Aug 12 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | V.P. & General Coun ... | Buy | M | 4.40 | 25,000 | 110,000 | 25,000 | 0 to 25 K |
Aug 12 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | V.P. & General Coun ... | Sell | S | 15.38 | 25,000 | 384,500 | 0 | 25 K to 0 (-100.00 %) |
Aug 12 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | V.P. & General Coun ... | Buy | M | 4.40 | 25,000 | 110,000 | 25,000 | 0 to 25 K |
Aug 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.47 | 25,000 | 386,750 | 1,429,634 | 1.5 M to 1.4 M (-1.72 %) |
Aug 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.54 | 166 | 2,580 | 1,454,634 | 1.5 M to 1.5 M (-0.01 %) |
Aug 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.46 | 4,800 | 74,208 | 1,454,800 | 1.5 M to 1.5 M (-0.33 %) |
Aug 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.48 | 200 | 3,096 | 1,459,600 | 1.5 M to 1.5 M (-0.01 %) |
Aug 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.53 | 5,000 | 77,650 | 1,459,800 | 1.5 M to 1.5 M (-0.34 %) |
Aug 12 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.42 | 30,000 | 462,600 | 1,193,730 | 1.2 M to 1.2 M (-2.45 %) |
Aug 10 2004 | DOVP | Euthymics Bioscien ... | ELAN CORP PLC | 10% Owner | Sell | S | 16.00 | 200,000 | 3,200,000 | 2,195,362 | 2.4 M to 2.2 M (-8.35 %) |
Aug 10 2004 | DOVP | Euthymics Bioscien ... | ELAN CORP PLC | 10% Owner | Sell | S | 16.10 | 100,000 | 1,610,000 | 2,395,362 | 2.5 M to 2.4 M (-4.01 %) |
Jul 19 2004 | DOVP | Euthymics Bioscien ... | ELAN CORP PLC | 10% Owner | Sell | S | 14.00 | 14,800 | 207,200 | 2,495,362 | 2.5 M to 2.5 M (-0.59 %) |
Jul 09 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Grant | A | 13.55 | 15,000 | 203,250 | 203,200 | 188.2 K to 203.2 K (+7.97 %) |
Jul 09 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Grant | A | 13.55 | 15,000 | 203,250 | 69,300 | 54.3 K to 69.3 K (+27.62 %) |
Jul 09 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Grant | A | 13.55 | 15,000 | 203,250 | 121,200 | 106.2 K to 121.2 K (+14.12 %) |
Jul 09 2004 | DOVP | Euthymics Bioscien ... | ELAN CORP PLC | 10% Owner | Sell | S | 13.91 | 50,000 | 695,500 | 2,510,162 | 2.6 M to 2.5 M (-1.95 %) |
Jul 09 2004 | DOVP | Euthymics Bioscien ... | ELAN CORP PLC | 10% Owner | Sell | S | 13.95 | 50,000 | 697,500 | 2,560,162 | 2.6 M to 2.6 M (-1.92 %) |
Jul 07 2004 | DOVP | Euthymics Bioscien ... | ELAN CORP PLC | 10% Owner | Sell | S | 14.00 | 110,000 | 1,540,000 | 2,610,162 | 2.7 M to 2.6 M (-4.04 %) |
Jul 02 2004 | DOVP | Euthymics Bioscien ... | ELAN CORP PLC | 10% Owner | Sell | S | 13.90 | 160,000 | 2,224,000 | 2,720,162 | 2.9 M to 2.7 M (-5.56 %) |
Jul 02 2004 | DOVP | Euthymics Bioscien ... | ELAN CORP PLC | 10% Owner | Sell | S | 13.91 | 12,000 | 166,920 | 2,880,162 | 2.9 M to 2.9 M (-0.41 %) |
Jul 02 2004 | DOVP | Euthymics Bioscien ... | ELAN CORP PLC | 10% Owner | Sell | S | 14.00 | 2,500 | 35,000 | 2,892,162 | 2.9 M to 2.9 M (-0.09 %) |
Jul 02 2004 | DOVP | Euthymics Bioscien ... | ELAN CORP PLC | 10% Owner | Sell | S | 14.08 | 12,500 | 175,950 | 2,894,662 | 2.9 M to 2.9 M (-0.43 %) |
Jul 02 2004 | DOVP | Euthymics Bioscien ... | ELAN CORP PLC | 10% Owner | Sell | S | 14.01 | 65,000 | 910,650 | 2,907,162 | 3 M to 2.9 M (-2.19 %) |
Jul 02 2004 | DOVP | Euthymics Bioscien ... | ELAN CORP PLC | 10% Owner | Sell | S | 14.05 | 36,479 | 512,530 | 2,972,162 | 3 M to 3 M (-1.21 %) |
Jul 02 2004 | DOVP | Euthymics Bioscien ... | ELAN CORP PLC | 10% Owner | Sell | S | 14.05 | 35,220 | 494,841 | 3,008,641 | 3 M to 3 M (-1.16 %) |
Jun 07 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.00 | 100,000 | 1,500,000 | 1,223,730 | 1.3 M to 1.2 M (-7.55 %) |
May 19 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.11 | 20,000 | 302,200 | 61,000 | 81 K to 61 K (-24.69 %) |
Jun 03 2004 | DOVP | Euthymics Bioscien ... | ELAN CORP PLC | 10% Owner | Buy | C | 3.98 | 2,907,162 | 11,570,505 | 3,043,861 | 136.7 K to 3 M (+2,126.69 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.50 | 10,000 | 155,000 | 1,323,730 | 1.3 M to 1.3 M (-0.75 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.51 | 5,000 | 77,550 | 1,333,730 | 1.3 M to 1.3 M (-0.37 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.56 | 2,500 | 38,900 | 1,338,730 | 1.3 M to 1.3 M (-0.19 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.59 | 2,500 | 38,975 | 1,341,230 | 1.3 M to 1.3 M (-0.19 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.50 | 20,000 | 310,000 | 1,343,730 | 1.4 M to 1.3 M (-1.47 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.40 | 15,000 | 231,000 | 1,363,730 | 1.4 M to 1.4 M (-1.09 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.24 | 2,500 | 38,100 | 1,378,730 | 1.4 M to 1.4 M (-0.18 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.10 | 2,500 | 37,750 | 1,381,230 | 1.4 M to 1.4 M (-0.18 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.08 | 2,500 | 37,700 | 1,383,730 | 1.4 M to 1.4 M (-0.18 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.05 | 2,500 | 37,625 | 1,386,230 | 1.4 M to 1.4 M (-0.18 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.00 | 7,500 | 112,500 | 1,388,730 | 1.4 M to 1.4 M (-0.54 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.00 | 5,000 | 75,000 | 1,396,230 | 1.4 M to 1.4 M (-0.36 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.07 | 2,500 | 37,675 | 1,401,230 | 1.4 M to 1.4 M (-0.18 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.23 | 5,000 | 76,150 | 1,403,730 | 1.4 M to 1.4 M (-0.35 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.22 | 5,000 | 76,100 | 1,408,730 | 1.4 M to 1.4 M (-0.35 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.21 | 2,000 | 30,420 | 1,413,730 | 1.4 M to 1.4 M (-0.14 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.25 | 3,000 | 45,750 | 1,415,730 | 1.4 M to 1.4 M (-0.21 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.45 | 1,000 | 15,450 | 1,418,730 | 1.4 M to 1.4 M (-0.07 %) |
May 13 2004 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.40 | 4,000 | 61,600 | 1,419,730 | 1.4 M to 1.4 M (-0.28 %) |
Apr 28 2004 | DOVP | Euthymics Bioscien ... | ELAN CORP PLC | 10% Owner | Option Exercise | X | 10.00 | 75,000 | 750,000 | 0 | |
Apr 28 2004 | DOVP | Euthymics Bioscien ... | ELAN CORP PLC | 10% Owner | Option Exercise | X | 3.41 | 121,500 | 414,315 | 0 | |
Apr 28 2004 | DOVP | Euthymics Bioscien ... | ELAN CORP PLC | 10% Owner | Sell | S | 19.20 | 480,921 | 9,233,683 | 136,699 | 617.6 K to 136.7 K (-77.87 %) |
Apr 28 2004 | DOVP | Euthymics Bioscien ... | ELAN CORP PLC | 10% Owner | Sell | S | 19.30 | 5,000 | 96,500 | 617,620 | 622.6 K to 617.6 K (-0.80 %) |
Apr 28 2004 | DOVP | Euthymics Bioscien ... | ELAN CORP PLC | 10% Owner | Sell | S | 19.30 | 5,800 | 111,961 | 622,620 | 628.4 K to 622.6 K (-0.92 %) |
Apr 28 2004 | DOVP | Euthymics Bioscien ... | ELAN CORP PLC | 10% Owner | Sell | S | 19.33 | 30,900 | 597,143 | 628,420 | 659.3 K to 628.4 K (-4.69 %) |
Apr 28 2004 | DOVP | Euthymics Bioscien ... | ELAN CORP PLC | 10% Owner | Sell | S | 19.33 | 200 | 3,866 | 659,320 | 659.5 K to 659.3 K (-0.03 %) |
Apr 28 2004 | DOVP | Euthymics Bioscien ... | ELAN CORP PLC | 10% Owner | Sell | S | 19.35 | 46,800 | 905,580 | 659,520 | 706.3 K to 659.5 K (-6.63 %) |